Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
$842M |
| 2 |
NVIDIA
NVDA
|
$559M |
| 3 |
Microsoft
MSFT
|
$420M |
| 4 |
Apple
AAPL
|
$389M |
| 5 |
Moderna
MRNA
|
$365M |
Top Sells
| 1 |
Baidu
BIDU
|
$628M |
| 2 |
Tesla
TSLA
|
$424M |
| 3 |
Palo Alto Networks
PANW
|
$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$415M |
| 5 |
AT&T
T
|
$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$251B
| $2.03B | 2.53% | 24,181,071 -665,600 | -3% | -$55.8M |
|
2
VeriSign
VRSN
$25.5B
| $1.1B | 1.38% | 4,841,290 -27,024 | -0.6% | -$6.15M |
|
3
Zoom
ZM
$24.4B
| $1.03B | 1.29% | 2,662,863 +142,000 | +6% | +$55M |
|
|
4
NVIDIA
NVDA
$4.24T
| $929M | 1.16% | 1,160,793 +698,500 | +151% | +$559M |
|
|
5
Amazon
AMZN
$2.44T
| $897M | 1.12% | 260,655 +244,800 | +1,544% | +$842M |
|
6
Target
TGT
$43.6B
| $870M | 1.09% | 3,600,559 +14,500 | +0.4% | +$3.51M |
|
7
Atlassian
TEAM
$46.6B
| $846M | 1.06% | 3,293,360 -48,060 | -1% | -$12.3M |
|
|
8
Moderna
MRNA
$9.37B
| $749M | 0.94% | 3,188,454 +1,552,925 | +95% | +$365M |
|
9
Kroger
KR
$44.9B
| $679M | 0.85% | 17,731,571 +557,500 | +3% | +$21.4M |
|
10
Monster Beverage
MNST
$60.9B
| $656M | 0.82% | 7,177,560 -779,200 | -10% | -$71.2M |
|
11
Franco-Nevada
FNV
$36.3B
| $634M | 0.79% | 4,369,790 -467,600 | -10% | -$67.8M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $578M | 0.72% | 3,147,521 -180,600 | -5% | -$33.2M |
|
13
Domino's
DPZ
$15.6B
| $573M | 0.72% | 1,228,025 +291,600 | +31% | +$136M |
|
14
Molina Healthcare
MOH
$9.8B
| $569M | 0.71% | 2,248,465 -217,950 | -9% | -$55.2M |
|
|
15
Microsoft
MSFT
$3.77T
| $561M | 0.7% | 2,069,184 +1,549,000 | +298% | +$420M |
|
|
16
Apple
AAPL
$3.45T
| $559M | 0.7% | 4,078,632 +2,841,100 | +230% | +$389M |
|
17
United Therapeutics
UTHR
$13.8B
| $558M | 0.7% | 3,110,191 -97,400 | -3% | -$17.5M |
|
18
Hershey
HSY
$37.3B
| $556M | 0.69% | 3,192,466 -168,795 | -5% | -$29.4M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $524M | 0.65% | 1,678,923 -101,200 | -6% | -$31.6M |
|
20
Vodafone
VOD
$28.8B
| $511M | 0.64% | 29,809,976 -2,500,100 | -8% | -$42.8M |
|
21
Bristol-Myers Squibb
BMY
$96B
| $488M | 0.61% | 7,305,925 +333,738 | +5% | +$22.3M |
|
|
22
Alphabet (Google) Class A
GOOGL
$2.57T
| $483M | 0.6% | 197,848 -16,500 | -8% | -$40.3M |
|
23
Herbalife
HLF
$1.01B
| $469M | 0.59% | 8,894,664 -140,100 | -2% | -$7.39M |
|
24
Biogen
BIIB
$19.4B
| $461M | 0.57% | 1,330,003 -608,159 | -31% | -$211M |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $459M | 0.57% | 2,277,284 -123,000 | -5% | -$24.8M |
|